MCID: CRV045
MIFTS: 38

Cervical Intraepithelial Neoplasia

Categories: Rare diseases

Aliases & Classifications for Cervical Intraepithelial Neoplasia

MalaCards integrated aliases for Cervical Intraepithelial Neoplasia:

Name: Cervical Intraepithelial Neoplasia 50 52 69
Cin 45

Classifications:



Summaries for Cervical Intraepithelial Neoplasia

MalaCards based summary : Cervical Intraepithelial Neoplasia, also known as cin, is related to cervix uteri carcinoma in situ and cervicitis. An important gene associated with Cervical Intraepithelial Neoplasia is CDKN2A (Cyclin Dependent Kinase Inhibitor 2A), and among its related pathways/superpathways is Validated targets of C-MYC transcriptional activation. The drugs Bupivacaine and Epinephrine have been mentioned in the context of this disorder. Affiliated tissues include cervix, testes and t cells, and related phenotypes are Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) and mortality/aging

Wikipedia : 72 Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is the potentially... more...

Related Diseases for Cervical Intraepithelial Neoplasia

Diseases related to Cervical Intraepithelial Neoplasia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 81)
id Related Disease Score Top Affiliating Genes
1 cervix uteri carcinoma in situ 11.3
2 cervicitis 11.2
3 split hand split foot nystagmus 10.8 CDKN2A MKI67
4 amelogenesis imperfecta local hypoplastic 10.7 CDKN2A MKI67
5 bladder colloid adenocarcinoma 10.7 CDKN2A MKI67
6 aplastic anemia 10.7 TERC TERT
7 brachial amelia, forebrain defects and facial clefts 10.7 CDKN2A TERT
8 insulin-resistant acanthosis nigricans, type a 10.7 TERC TERT
9 myeloid/lymphoid neoplasm associated with pdgfra rearrangement 10.7 BIRC5 CDKN2A
10 diffuse meningeal melanocytosis 10.6 CDKN2A TERT
11 orbital lymphoma 10.6 CDKN2A MKI67
12 boylan dew greco syndrome 10.6 KRT17 MKI67
13 epidural neoplasm 10.6 CDKN2A VEGFC
14 ataxia-telangiectasia 10.6 CDKN2A NME1
15 nasal cavity lymphoma 10.6 CDKN2A KRT8
16 dysmorphism cleft palate loose skin 10.6 TERC TERT
17 spindle cell liposarcoma 10.5 CDKN2A KRT8
18 squamous cell carcinoma 10.5
19 porphyria 10.5 MTHFR ODC1
20 sparse hair ptosis mental retardation 10.5 MKI67 TERT
21 plasmodium ovale malaria 10.4 CDKN2A MKI67
22 gastrointestinal stromal tumor 10.4 CDKN2A MKI67 MTHFR
23 colon squamous cell carcinoma 10.4 CDKN2A KRT8
24 rare endometriosis 10.4 BIRC5 CDKN2A TERT
25 pediatric meningioma 10.4 BIRC5 MKI67 TERT
26 nail disorder, nonsyndromic congenital, 1 10.4 BIRC5 CDKN2A TERT
27 middle ear squamous cell carcinoma 10.4 CDKN2A KRT17 KRT8
28 ductal carcinoma in situ 10.4 CDKN2A KRT17 KRT8
29 hodgkin's lymphoma, mixed cellularity 10.3 CDKN2A TERT VEGFC
30 nontoxic goiter 10.3 CDKN2A FHIT
31 vaginitis 10.3
32 papilloma 10.3
33 levy-yeboa syndrome 10.2 KRT8 MKI67
34 adenocarcinoma 10.2
35 cervical squamous cell carcinoma 10.2
36 endocervicitis 10.2
37 breast duct papilloma 10.2 KRT8 MKI67 NME1
38 cervical cancer, somatic 10.2 CDKN2A MKI67 TERT
39 hiv-1 10.2
40 adenocarcinoma in situ 10.2
41 larynx carcinoma in situ 10.1 CDKN2A FHIT KRT17
42 childhood type dermatomyositis 10.1 CDKN2A KRT17 KRT8 MKI67
43 differentiating neuroblastoma 10.1 KRT8 TERT
44 chlamydia 10.1
45 bacterial vaginosis 10.1
46 oral antidiabetic drugs toxicity or dose selection 10.1 BIRC5 FHIT MKI67
47 autonomic nervous system neoplasm 10.1 CDKN2A KRT8 ODC1
48 childhood oligodendroglioma 10.1 CDKN2A MKI67
49 breast granular cell tumor 10.0 KRT8 NME1 VEGFC
50 retinoblastoma 10.0

Graphical network of the top 20 diseases related to Cervical Intraepithelial Neoplasia:



Diseases related to Cervical Intraepithelial Neoplasia

Symptoms & Phenotypes for Cervical Intraepithelial Neoplasia

GenomeRNAi Phenotypes related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased cell death in breast cancer cell lines (MCF10A, MDA-MB-435) GR00104-A-0 8.8 CDC6 MKI67 RBL1

MGI Mouse Phenotypes related to Cervical Intraepithelial Neoplasia:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 mortality/aging MP:0010768 9.7 BIRC5 CDKN2A FHIT KRT17 KRT8 MTHFR
2 digestive/alimentary MP:0005381 9.63 KRT17 KRT8 RBL1 TERT CDKN2A FHIT
3 neoplasm MP:0002006 9.02 CDKN2A FHIT NME1 RBL1 TERT

Drugs & Therapeutics for Cervical Intraepithelial Neoplasia

Drugs for Cervical Intraepithelial Neoplasia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 193)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
2
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2 51-43-4 5816
3 Racepinephrine Approved Phase 4,Phase 3,Phase 2
4
Aluminum hydroxide Approved Phase 4,Phase 3 21645-51-2
5 Vaccines Phase 4,Phase 3,Phase 1,Phase 2
6 Adrenergic Agents Phase 4,Phase 2
7 Adrenergic Agonists Phase 4,Phase 2
8 Adrenergic alpha-Agonists Phase 4,Phase 2
9 Adrenergic beta-Agonists Phase 4,Phase 2
10 Anesthetics Phase 4,Phase 3,Phase 2
11 Anesthetics, Local Phase 4,Phase 3,Phase 2
12 Anti-Asthmatic Agents Phase 4,Phase 2
13 Autonomic Agents Phase 4,Phase 2
14 Bronchodilator Agents Phase 4,Phase 2
15 Central Nervous System Depressants Phase 4,Phase 3,Phase 2
16 Epinephryl borate Phase 4,Phase 3,Phase 2
17 Mydriatics Phase 4,Phase 2
18 Neurotransmitter Agents Phase 4,Phase 2
19 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1
20 Respiratory System Agents Phase 4,Phase 2
21 Vasoconstrictor Agents Phase 4,Phase 2
22 Estrogens Phase 4
23 Estrogens, Conjugated (USP) Phase 4
24 Hormone Antagonists Phase 4,Phase 2
25 Hormones Phase 4,Phase 2
26 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2
27 Monophosphoryl lipid A Phase 4
28
Menthol Approved Phase 2, Phase 3 2216-51-5 16666
29
Imiquimod Approved, Investigational Phase 2, Phase 3, Phase 1 99011-02-6 57469
30
Fluorouracil Approved Phase 3,Phase 1 51-21-8 3385
31
Lidocaine Approved, Vet_approved Phase 3,Phase 2 137-58-6 3676
32
Isotretinoin Approved Phase 3 4759-48-2 5538 5282379
33
Aluminum sulfate Approved Phase 3 10043-01-3
34
acetic acid Approved, Nutraceutical Phase 3,Phase 1 64-19-7 176
35
Fenretinide Investigational Phase 3,Phase 2 65646-68-6
36 Interferon Inducers Phase 2, Phase 3, Phase 1
37 interferons Phase 2, Phase 3, Phase 1
38 Antibodies Phase 3
39 Immunoglobulins Phase 3
40 Gastrointestinal Agents Phase 3,Phase 2,Phase 1
41 Anti-Infective Agents Phase 3,Phase 2,Phase 1,Early Phase 1
42 Antiviral Agents Phase 3,Phase 2,Phase 1
43 Adjuvants, Immunologic Phase 2, Phase 3, Phase 1
44 Hemostatics Phase 3,Phase 2
45 Antimetabolites Phase 3,Phase 1
46 Antimetabolites, Antineoplastic Phase 3,Phase 1
47 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
48 Protective Agents Phase 3,Phase 1,Phase 2
49 Retinamide Phase 3,Phase 2
50 Anti-Arrhythmia Agents Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 328)

id Name Status NCT ID Phase Drugs
1 Can Alternative Treatment Have an Impact on Cervical Dysplasia? Unknown status NCT00842738 Phase 4
2 The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling Unknown status NCT01843478 Phase 4
3 Management of Cervical Intraepithelial Neoplasia Grade 2 Completed NCT00733109 Phase 4
4 V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) Completed NCT01544478 Phase 4
5 Hemodynamic Stability of Bupivacaine With and Without Adrenaline for Paracervical Block for Cervical Conization Completed NCT02368054 Phase 4 Bupivacaine;Adrenaline
6 Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Completed NCT01034358 Phase 4
7 Effect of Hormone Replacement Therapy on Lupus Activity Completed NCT00392093 Phase 4 Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
8 HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions Recruiting NCT03051516 Phase 4
9 The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) Active, not recruiting NCT02629510 Phase 4 Tachosil
10 FASTER-Tlalpan Study Active, not recruiting NCT03105856 Phase 4
11 CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening (CITRUS Study) Active, not recruiting NCT01895517 Phase 4
12 Effectiveness of Cervical Screening in HPV Vaccinated Women Enrolling by invitation NCT02149030 Phase 4
13 Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV) Unknown status NCT01095198 Phase 2, Phase 3
14 A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls Unknown status NCT02562508 Phase 3
15 Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants Completed NCT00128661 Phase 3
16 ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial Completed NCT00941252 Phase 2, Phase 3 Topical imiquimod therapy
17 Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia Completed NCT00212381 Phase 3 di indolylmethane (DIM)
18 Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial Completed NCT02330471 Phase 3
19 Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study Completed NCT00929526 Phase 3
20 Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix Completed NCT02130323 Phase 2, Phase 3 Imiquimod
21 Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED) Completed NCT00092521 Phase 3
22 Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit Completed NCT00237562 Phase 3
23 A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women Completed NCT00000758 Phase 3 Fluorouracil
24 A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix Completed NCT00264732 Phase 2, Phase 3 Amolimogene;Amolimogene
25 Fenretinide in Treating Patients With Cervical Neoplasia Completed NCT00003075 Phase 3 Fenretinide
26 Diindolylmethane in Treating Patients With Abnormal Cervical Cells Completed NCT00462813 Phase 3 oral microencapsulated diindolylmethane
27 A Trial of Two Electrosurgical Conizations: Histopathological Analysis of Excision Margins Completed NCT01929993 Phase 3
28 Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial Completed NCT01505920 Phase 3
29 Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1 Completed NCT00156026 Phase 3
30 Efficacy Study of Diathermy Cone Biopsy for the Treatment of Cervical Intraepithelial Lesion Completed NCT00995020 Phase 3
31 Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS) Completed NCT01131312 Phase 3
32 Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women Completed NCT00337818 Phase 3
33 Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil)(V501-015) Completed NCT00092534 Phase 3
34 Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine Completed NCT00316706 Phase 3
35 Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18 Completed NCT00122681 Phase 3
36 Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention Completed NCT01014026 Phase 3
37 Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects Completed NCT00779766 Phase 3
38 Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older Completed NCT00294047 Phase 3
39 A Study to Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019) Completed NCT00090220 Phase 3
40 Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors Completed NCT00001073 Phase 3 Isotretinoin
41 Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System Completed NCT00973362 Phase 3
42 Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041) Completed NCT00834106 Phase 3
43 REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) Recruiting NCT03185013 Phase 3
44 Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix Recruiting NCT02346227 Phase 3 AV2;Placebo
45 Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions Recruiting NCT02059499 Phase 3 imiquimod;fluorouracil
46 Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions Recruiting NCT02135419 Phase 3 imiquimod;fluorouracil
47 A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine. Active, not recruiting NCT02733068 Phase 3
48 Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine Active, not recruiting NCT01735006 Phase 3
49 Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol Not yet recruiting NCT02669459 Phase 3 Imiquimod
50 HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV Not yet recruiting NCT03284866 Phase 3

Search NIH Clinical Center for Cervical Intraepithelial Neoplasia

Genetic Tests for Cervical Intraepithelial Neoplasia

Anatomical Context for Cervical Intraepithelial Neoplasia

MalaCards organs/tissues related to Cervical Intraepithelial Neoplasia:

39
Cervix, Testes, T Cells, Skin, Bone, Kidney, Bone Marrow

Publications for Cervical Intraepithelial Neoplasia

Articles related to Cervical Intraepithelial Neoplasia:

(show top 50) (show all 784)
id Title Authors Year
1
A retrospective analysis on 1901 women with high grade cervical intraepithelial neoplasia by colposcopic biopsy. ( 28850822 )
2017
2
The use of cold coagulation for the treatment of cervical intraepithelial neoplasia. ( 28737306 )
2017
3
The Neutrophil-Lymphocyte Ratio Predicts Recurrence of Cervical Intraepithelial Neoplasia. ( 28819422 )
2017
4
Re: Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study. ( 28921789 )
2017
5
Type-specific human papillomavirus prevalence in cervical intraepithelial neoplasia and cancer in Iran. ( 28786495 )
2017
6
Validity Parameters of the Human Papillomavirus Detection Test Hybrid Capture 2 With and Without Cytology After Laser Destruction and Large Loop Excision of the Transformation Zone Treatment of High-Grade Cervical Intraepithelial Neoplasia Lesions. ( 28953121 )
2017
7
Cryotherapy reduces progression of cervical intraepithelial neoplasia grade 1 in South African HIV-infected women: a randomized, controlled trial. ( 28902073 )
2017
8
Type-Dependent Association between Risk of Cervical Intraepithelial Neoplasia and Viral Load of Oncogenic Human Papillomavirus Types Other than Types 16 and 18. ( 28052328 )
2017
9
Diagnostic and Treatment Reproducibility of Cervical Intraepithelial Neoplasia / Squamous Intraepithelial Lesion and Factors Affecting the Diagnosis. ( 28832077 )
2017
10
Whole-genome analysis of human papillomavirus genotypes 52 and 58 isolated from Japanese women with cervical intraepithelial neoplasia and invasive cervical cancer. ( 28785305 )
2017
11
Authors' reply re: Assessing cervical intraepithelial neoplasia as an indicator disease for HIV in a low endemic setting: a population-based register study. ( 28921796 )
2017
12
Translation and cultural adaptation of the Functional Assessment of Chronic Illness Therapy - Cervical Dysplasia (FACIT-CD) to evaluate quality of life in women with cervical intraepithelial neoplasia. ( 28767912 )
2017
13
Influence of co-infection complicated with human papillomavirus on cervical intraepithelial neoplasia development in patients with atypical squamous cells of undetermined significance. ( 28923300 )
2017
14
Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome. ( 28705710 )
2017
15
A pilot study on Hla-G locus control region haplotypes and cervical intraepithelial neoplasias. ( 27998803 )
2017
16
Bacterial Vaginosis and Cervical Intraepithelial Neoplasia: Is there an Association or is Co-Existence Incidental? ( 28610416 )
2017
17
Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia? ( 28817235 )
2017
18
Nanomechanical Characteristics of Cervical Cancer and Cervical Intraepithelial Neoplasia Revealed by Atomic Force Microscopy. ( 28859048 )
2017
19
Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status. ( 28833798 )
2017
20
Effects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial. ( 28050798 )
2017
21
Cervical intraepithelial neoplasia (CIN) 3-like squamous cell carcinoma of the cervix: a review of 14 cases with comparison of E-cadherin and cyclin D1 expression in the CIN 3-like and infiltrative tumour elements. ( 27681166 )
2017
22
The impact of bivalent HPV vaccine on cervical intraepithelial neoplasia by deprivation in Scotland: reducing the gap. ( 28756395 )
2017
23
Expression of p63, p53 and Ki-67 in Patients with Cervical Intraepithelial Neoplasia. ( 28044307 )
2017
24
A prediction model for spontaneous regression of cervical intraepithelial neoplasia grade 2, based on simple clinical parameters. ( 27697590 )
2017
25
Digital Colposcopy With Dynamic Spectral Imaging for Detection of Cervical Intraepithelial Neoplasia 2+ in Low-Grade Referrals: The IMPROVE-COLPO Study. ( 28953107 )
2017
26
Influence of Human Papillomavirus Infection on the Natural History of Cervical Intraepithelial Neoplasia 1: A Meta-Analysis. ( 28812024 )
2017
27
LINE-1 hypermethylation in white blood cell DNA is associated with high-grade cervical intraepithelial neoplasia. ( 28854904 )
2017
28
Threshold cost-effectiveness analysis for a therapeutic vaccine against HPV-16/18-positive cervical intraepithelial neoplasia in the Netherlands. ( 27816370 )
2016
29
Short-Term Efficacy of Trichloroacetic Acid in the Treatment of Cervical Intraepithelial Neoplasia. ( 26942365 )
2016
30
Cervical Microbiota Associated with Higher Grade Cervical Intraepithelial Neoplasia in Women Infected with High-Risk Human Papillomaviruses. ( 26935422 )
2016
31
Meta-analysis of cold-knife conization versus loop electrosurgical excision procedure for cervical intraepithelial neoplasia. ( 27418835 )
2016
32
Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial. ( 27541373 )
2016
33
TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial. ( 26897518 )
2016
34
A circulating serum miRNA panel as early detection biomarkers of cervical intraepithelial neoplasia. ( 27981553 )
2016
35
Risk of head-and-neck cancer following a diagnosis of severe cervical intraepithelial neoplasia: a nationwide population-based cohort study in Denmark. ( 27106016 )
2016
36
SOX2 Expression in Cervical Intraepithelial Neoplasia Grade 3 (CIN3) and Superficially Invasive (Stage IA1) Squamous Carcinoma of the Cervix. ( 26886477 )
2016
37
Risk factors for residual disease after cervical conization in patients with cervical intraepithelial neoplasia grades 2 and 3 and positive surgical margins. ( 27038228 )
2016
38
Pooled analysis of genome-wide association studies of cervical intraepithelial neoplasia 3 (CIN3) identifies a new susceptibility locus. ( 27285765 )
2016
39
Combined effect of diet and cervical microbiome on the risk of cervical intraepithelial neoplasia. ( 27075319 )
2016
40
Genome-wide profiling of the human papillomavirus DNA integration in cervical intraepithelial neoplasia and normal cervical epithelium by HPV capture technology. ( 27759101 )
2016
41
Value of p16(INK4a) and Ki-67 Immunohistochemical Staining in Cervical Intraepithelial Neoplasia Grade 2 Biopsies as Biomarkers for Cervical Intraepithelial Neoplasia Grade 3 in Cone Results. ( 27363060 )
2016
42
Adverse Pregnancy Outcomes After Treatment for Cervical Intraepithelial Neoplasia. ( 27824756 )
2016
43
Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia. ( 27401842 )
2016
44
Glycodelin expression in pregnant patients with cervical intraepithelial neoplasia: a case-control study. ( 26631447 )
2016
45
Association of -463G/A MPO gene polymorphism and risk of cervical intraepithelial neoplasia. ( 26319155 )
2016
46
Serial measurement of type-specific human papillomavirus load enables classification of cervical intraepithelial neoplasia lesions according to occurring human papillomavirus-induced pathway. ( 26890987 )
2016
47
Increase in the cervical length after the loop electrosurgical excision procedure for grade III cervical intraepithelial neoplasia. ( 27924675 )
2016
48
Cervical intraepithelial neoplasia: screening and management. ( 27487071 )
2016
49
Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden. ( 27177207 )
2016
50
Accuracy of Colposcopically Guided Diagnostic Methods for the Detection of Cervical Intraepithelial Neoplasia. ( 26941452 )
2016

Variations for Cervical Intraepithelial Neoplasia

Expression for Cervical Intraepithelial Neoplasia

Search GEO for disease gene expression data for Cervical Intraepithelial Neoplasia.

Pathways for Cervical Intraepithelial Neoplasia

Pathways related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 10.83 BIRC5 NME1 ODC1 TERT

GO Terms for Cervical Intraepithelial Neoplasia

Cellular components related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 intermediate filament GO:0005882 8.8 KRT17 KRT8 NME1

Biological processes related to Cervical Intraepithelial Neoplasia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 negative regulation of cell proliferation GO:0008285 9.46 CDC6 CDKN2A NME1 VEGFC
2 cell cycle GO:0007049 9.35 BIRC5 CDC6 CDKN2A MKI67 RBL1
3 nucleotide metabolic process GO:0009117 9.26 FHIT NME1
4 replicative senescence GO:0090399 8.62 CDKN2A TERT

Sources for Cervical Intraepithelial Neoplasia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....